Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074777 | SCV001240373 | pathogenic | Retinal dystrophy | 2019-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001204394 | SCV001375599 | pathogenic | not provided | 2022-11-02 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 866626). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individuals with Stargardt disease (PMID: 26593885, 30820146). This sequence change creates a premature translational stop signal (p.Gln305*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). |
Gene |
RCV001204394 | SCV001792490 | pathogenic | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | Observed with a second ABCA4 variant in a patient with Stargardt disease in published literature (PMID: 26593885); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30820146, 26593885, 35120629) |